Literature DB >> 9023055

Functions of fibroblast growth factors in vertebrate development.

M Goldfarb1.   

Abstract

Fibroblast growth factors (FGFs) are a class of secreted polypeptide ligands which mediate diverse cellular responses during embryonic, fetal, and postnatal vertebrate development. The purposes of this review are to provide a condensed overview of FGFs and their receptors, to catalog and categorize the functions of FGFs in vertebrate development, to present recent discoveries relating to the interplay of FGFs with other secreted ligands in the control of tissue growth and patterning, and to discuss several potential directions for future research in the field.

Mesh：

Substances：

Year:  1996        PMID： 9023055     DOI： 10.1016/s1359-6101(96)00039-1

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN： 1359-6101            Impact factor:   7.638


  47 in total

1.  Morphogenetic movements at gastrulation require the SH2 tyrosine phosphatase Shp2.

Authors:  T M Saxton; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins.

Authors:  S H Ong; Y R Hadari; N Gotoh; G R Guy; J Schlessinger; I Lax
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

Review 3.  Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction.

Authors:  Leanne M Cotton; Moira K O'Bryan; Barry T Hinton
Journal:  Endocr Rev       Date:  2008-01-23       Impact factor: 19.871

4.  Fgf8 morphogen gradient forms by a source-sink mechanism with freely diffusing molecules.

Authors:  Shuizi Rachel Yu; Markus Burkhardt; Matthias Nowak; Jonas Ries; Zdenek Petrásek; Steffen Scholpp; Petra Schwille; Michael Brand
Journal:  Nature       Date:  2009-09-09       Impact factor: 49.962

Review 5.  Talocalcaneal coalition in Muenke syndrome: report of a patient, review of the literature in FGFR-related craniosynostoses, and consideration of mechanism.

Authors:  Nneamaka B Agochukwu; Benjamin D Solomon; Laurel J Benson; Maximilian Muenke
Journal:  Am J Med Genet A       Date:  2013-02-01       Impact factor: 2.802

6.  Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice.

Authors:  D L Miller; S Ortega; O Bashayan; R Basch; C Basilico
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

7.  Activation of germline-specific genes is required for limb regeneration in the Mexican axolotl.

Authors:  Wei Zhu; Gerald M Pao; Akira Satoh; Gillian Cummings; James R Monaghan; Timothy T Harkins; Susan V Bryant; S Randal Voss; David M Gardiner; Tony Hunter
Journal:  Dev Biol       Date:  2012-07-27       Impact factor: 3.582

8.  Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management.

Authors:  Liesbeth Hameetman; Judith Vmg Bovée; Antonie Hm Taminiau; Herman M Kroon; Pancras Cw Hogendoorn
Journal:  Hered Cancer Clin Pract       Date:  2004-11-15       Impact factor: 2.857

9.  Novel system to investigate the effects of inhaled volume and rates of rise in simulated inspiratory air flow on fine particle output from a dry powder inhaler.

Authors:  Varsha Chavan; Richard Dalby
Journal:  AAPS PharmSci       Date:  2002

10.  The docking protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the phosphatidylinositol 3-kinase/Akt antiapoptotic pathway.

Authors:  Betty Lamothe; Masashi Yamada; Ute Schaeper; Walter Birchmeier; Irit Lax; Joseph Schlessinger
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.